ID   PLPP_HUMAN              Reviewed;         296 AA.
AC   Q96GD0; Q9UGY2;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=Pyridoxal phosphate phosphatase;
DE            Short=PLP phosphatase;
DE            EC=3.1.3.3 {ECO:0000269|PubMed:15580268};
DE            EC=3.1.3.74 {ECO:0000250|UniProtKB:P60487};
DE   AltName: Full=Chronophin;
GN   Name=PDXP; Synonyms=CIN, PLP, PLPP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, HOMODIMERIZATION, COFACTOR,
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=14522954; DOI=10.1074/jbc.M309619200;
RA   Jang Y.M., Kim D.W., Kang T.-C., Won M.H., Baek N.-I., Moon B.J.,
RA   Choi S.Y., Kwon O.-S.;
RT   "Human pyridoxal phosphatase. Molecular cloning, functional
RT   expression, and tissue distribution.";
RL   J. Biol. Chem. 278:50040-50046(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 19-35; 100-119 AND 145-158, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 19-30 AND 145-158, AND ENZYME ACTIVITY.
RX   PubMed=8132548;
RA   Gao G.-J., Fonda M.L.;
RT   "Identification of an essential cysteine residue in pyridoxal
RT   phosphatase from human erythrocytes.";
RL   J. Biol. Chem. 269:8234-8239(1994).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, COFACTOR, ACTIVE
RP   SITE, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-25, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15580268; DOI=10.1038/ncb1201;
RA   Gohla A., Birkenfeld J., Bokoch G.M.;
RT   "Chronophin, a novel HAD-type serine protein phosphatase, regulates
RT   cofilin-dependent actin dynamics.";
RL   Nat. Cell Biol. 7:21-29(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 2-296 IN COMPLEXES WITH
RP   PYRODOXAL PHOSPHATE; CALCIUM AND MAGNESIUM IONS.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
CC   -!- FUNCTION: Protein serine phosphatase that dephosphorylates 'Ser-3'
CC       in cofilin and probably also dephosphorylates phospho-serine
CC       residues in DSTN. Regulates cofilin-dependent actin cytoskeleton
CC       reorganization. Required for normal progress through mitosis and
CC       normal cytokinesis. Does not dephosphorylate phospho-threonines in
CC       LIMK1. Does not dephosphorylate peptides containing phospho-
CC       tyrosine (PubMed:15580268). Pyridoxal phosphate (PLP) phosphatase,
CC       which also catalyzes the dephosphorylation of pyridoxine 5'-
CC       phosphate (PNP) and pyridoxamine 5'-phosphate (PMP), with order of
CC       substrate preference PLP > PNP > PMP (PubMed:14522954).
CC       {ECO:0000269|PubMed:14522954, ECO:0000269|PubMed:15580268}.
CC   -!- CATALYTIC ACTIVITY: Pyridoxal 5'-phosphate + H(2)O = pyridoxal +
CC       phosphate. {ECO:0000250|UniProtKB:P60487}.
CC   -!- CATALYTIC ACTIVITY: O-phospho-L(or D)-serine + H(2)O = L(or D)-
CC       serine + phosphate. {ECO:0000269|PubMed:15580268}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14522954,
CC         ECO:0000269|PubMed:15580268};
CC       Note=Divalent metal ions. Mg(2+) is the most effective.
CC       {ECO:0000269|PubMed:14522954, ECO:0000269|PubMed:15580268};
CC   -!- ENZYME REGULATION: Inhibited by NaF, Zn(2+), Ca(2+), Mn(2+) and
CC       EDTA. {ECO:0000269|PubMed:15580268}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14522954}.
CC   -!- INTERACTION:
CC       P29066:Arrb1 (xeno); NbExp=2; IntAct=EBI-4303060, EBI-4303019;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:15580268}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:15580268}. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:15580268}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:15580268}; Cytoplasmic side
CC       {ECO:0000269|PubMed:15580268}. Cell projection, lamellipodium
CC       membrane {ECO:0000269|PubMed:15580268}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:15580268}; Cytoplasmic side
CC       {ECO:0000269|PubMed:15580268}. Cell membrane
CC       {ECO:0000269|PubMed:15580268}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:15580268}; Cytoplasmic side
CC       {ECO:0000269|PubMed:15580268}. Note=Colocalizes with the actin
CC       cytoskeleton in membrane ruffles and lamellipodia. Diffusely
CC       distributed throughout the cytosol during pro-metaphase and
CC       metaphase. Detected at the dynamic cell poles during telophase.
CC       Detected at the cleavage furrow and contractile ring during
CC       cytokinesis. Transiently detected at the plasma membrane in late
CC       stages of cytokinesis. Detected at the midbody.
CC       {ECO:0000269|PubMed:15580268}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in all the
CC       regions of central nerve system except the spinal cord. Also
CC       expressed at high level in liver and testis. In fetus, it is
CC       weakly expressed in all organs except brain.
CC       {ECO:0000269|PubMed:14522954, ECO:0000269|PubMed:15580268}.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY125047; AAM94358.1; -; mRNA.
DR   EMBL; Z83844; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000320; AAH00320.1; -; mRNA.
DR   EMBL; BC009756; AAH09756.2; -; mRNA.
DR   EMBL; BC064922; AAH64922.1; -; mRNA.
DR   CCDS; CCDS13953.1; -.
DR   RefSeq; NP_064711.1; NM_020315.4.
DR   UniGene; Hs.632762; -.
DR   PDB; 2CFR; X-ray; 2.40 A; A=1-296.
DR   PDB; 2CFS; X-ray; 2.40 A; A=1-296.
DR   PDB; 2CFT; X-ray; 1.80 A; A=1-296.
DR   PDB; 2OYC; X-ray; 1.72 A; A=2-296.
DR   PDB; 2P27; X-ray; 1.90 A; A=2-296.
DR   PDB; 2P69; X-ray; 2.25 A; A=2-296.
DR   PDBsum; 2CFR; -.
DR   PDBsum; 2CFS; -.
DR   PDBsum; 2CFT; -.
DR   PDBsum; 2OYC; -.
DR   PDBsum; 2P27; -.
DR   PDBsum; 2P69; -.
DR   ProteinModelPortal; Q96GD0; -.
DR   SMR; Q96GD0; -.
DR   BioGrid; 121330; 6.
DR   IntAct; Q96GD0; 2.
DR   STRING; 9606.ENSP00000215904; -.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DEPOD; Q96GD0; -.
DR   iPTMnet; Q96GD0; -.
DR   PhosphoSitePlus; Q96GD0; -.
DR   BioMuta; PDXP; -.
DR   DMDM; 44888310; -.
DR   REPRODUCTION-2DPAGE; IPI00025340; -.
DR   UCD-2DPAGE; Q96GD0; -.
DR   EPD; Q96GD0; -.
DR   MaxQB; Q96GD0; -.
DR   PaxDb; Q96GD0; -.
DR   PeptideAtlas; Q96GD0; -.
DR   PRIDE; Q96GD0; -.
DR   Ensembl; ENST00000215904; ENSP00000215904; ENSG00000241360.
DR   GeneID; 57026; -.
DR   KEGG; hsa:57026; -.
DR   UCSC; uc003atm.2; human.
DR   CTD; 57026; -.
DR   DisGeNET; 57026; -.
DR   GeneCards; PDXP; -.
DR   HGNC; HGNC:30259; PDXP.
DR   HPA; HPA000531; -.
DR   MIM; 609246; gene.
DR   neXtProt; NX_Q96GD0; -.
DR   OpenTargets; ENSG00000241360; -.
DR   PharmGKB; PA134882132; -.
DR   eggNOG; KOG2882; Eukaryota.
DR   eggNOG; COG0647; LUCA.
DR   GeneTree; ENSGT00510000047020; -.
DR   HOGENOM; HOG000068104; -.
DR   HOVERGEN; HBG049429; -.
DR   InParanoid; Q96GD0; -.
DR   KO; K07758; -.
DR   OMA; MIGDRLY; -.
DR   OrthoDB; EOG091G0I92; -.
DR   PhylomeDB; Q96GD0; -.
DR   TreeFam; TF314344; -.
DR   BRENDA; 3.1.3.74; 2681.
DR   SABIO-RK; Q96GD0; -.
DR   SIGNOR; Q96GD0; -.
DR   EvolutionaryTrace; Q96GD0; -.
DR   GenomeRNAi; 57026; -.
DR   PRO; PR:Q96GD0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000241360; -.
DR   CleanEx; HS_PDXP; -.
DR   ExpressionAtlas; Q96GD0; baseline and differential.
DR   Genevisible; Q96GD0; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:MGI.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IBA:GO_Central.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004647; F:phosphoserine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0033883; F:pyridoxal phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0031247; P:actin rod assembly; IDA:MGI.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:MGI.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; IMP:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0032361; P:pyridoxal phosphate catabolic process; ISS:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 3.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006357; HAD-SF_hydro_IIA.
DR   InterPro; IPR006349; PGP_euk.
DR   Pfam; PF13344; Hydrolase_6; 1.
DR   PIRSF; PIRSF000915; PGP-type_phosphatase; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01460; HAD-SF-IIA; 1.
DR   TIGRFAMs; TIGR01452; PGP_euk; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Hydrolase;
KW   Magnesium; Membrane; Metal-binding; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    296       Pyridoxal phosphate phosphatase.
FT                                /FTId=PRO_0000068837.
FT   REGION       58     62       Substrate binding.
FT   ACT_SITE     25     25       Nucleophile.
FT                                {ECO:0000269|PubMed:15580268}.
FT   ACT_SITE     27     27       Proton donor.
FT                                {ECO:0000305|PubMed:15580268}.
FT   METAL        25     25       Magnesium.
FT   METAL        27     27       Magnesium; via carbonyl oxygen.
FT   METAL       238    238       Magnesium.
FT   BINDING     182    182       Substrate.
FT   BINDING     213    213       Substrate.
FT   MUTAGEN      25     25       D->N: Abolishes phosphatase activity.
FT                                {ECO:0000269|PubMed:15580268}.
FT   HELIX         9     18       {ECO:0000244|PDB:2OYC}.
FT   STRAND       20     24       {ECO:0000244|PDB:2OYC}.
FT   TURN         27     29       {ECO:0000244|PDB:2OYC}.
FT   STRAND       30     32       {ECO:0000244|PDB:2OYC}.
FT   HELIX        40     49       {ECO:0000244|PDB:2OYC}.
FT   STRAND       53     58       {ECO:0000244|PDB:2OYC}.
FT   HELIX        65     74       {ECO:0000244|PDB:2OYC}.
FT   HELIX        82     84       {ECO:0000244|PDB:2OYC}.
FT   STRAND       85     87       {ECO:0000244|PDB:2OYC}.
FT   HELIX        88     99       {ECO:0000244|PDB:2OYC}.
FT   STRAND      104    106       {ECO:0000244|PDB:2OYC}.
FT   STRAND      109    114       {ECO:0000244|PDB:2OYC}.
FT   HELIX       116    124       {ECO:0000244|PDB:2OYC}.
FT   STRAND      143    148       {ECO:0000244|PDB:2OYC}.
FT   HELIX       156    166       {ECO:0000244|PDB:2OYC}.
FT   STRAND      171    176       {ECO:0000244|PDB:2OYC}.
FT   STRAND      181    183       {ECO:0000244|PDB:2OYC}.
FT   STRAND      189    191       {ECO:0000244|PDB:2OYC}.
FT   HELIX       193    204       {ECO:0000244|PDB:2OYC}.
FT   HELIX       217    225       {ECO:0000244|PDB:2OYC}.
FT   HELIX       230    232       {ECO:0000244|PDB:2OYC}.
FT   STRAND      233    238       {ECO:0000244|PDB:2OYC}.
FT   TURN        240    242       {ECO:0000244|PDB:2OYC}.
FT   HELIX       243    250       {ECO:0000244|PDB:2OYC}.
FT   STRAND      253    261       {ECO:0000244|PDB:2OYC}.
FT   HELIX       264    272       {ECO:0000244|PDB:2OYC}.
FT   HELIX       276    278       {ECO:0000244|PDB:2OYC}.
FT   STRAND      281    286       {ECO:0000244|PDB:2OYC}.
FT   HELIX       287    293       {ECO:0000244|PDB:2OYC}.
SQ   SEQUENCE   296 AA;  31698 MW;  33466C35A76B458C CRC64;
     MARCERLRGA ALRDVLGRAQ GVLFDCDGVL WNGERAVPGA PELLERLARA GKAALFVSNN
     SRRARPELAL RFARLGFGGL RAEQLFSSAL CAARLLRQRL PGPPDAPGAV FVLGGEGLRA
     ELRAAGLRLA GDPSAGDGAA PRVRAVLVGY DEHFSFAKLR EACAHLRDPE CLLVATDRDP
     WHPLSDGSRT PGTGSLAAAV ETASGRQALV VGKPSPYMFE CITENFSIDP ARTLMVGDRL
     ETDILFGHRC GMTTVLTLTG VSRLEEAQAY LAAGQHDLVP HYYVESIADL TEGLED
//
